Simrat Randhawa

763 total citations · 1 hit paper
13 papers, 424 citations indexed

About

Simrat Randhawa is a scholar working on Rheumatology, Hepatology and Molecular Biology. According to data from OpenAlex, Simrat Randhawa has authored 13 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 9 papers in Hepatology and 3 papers in Molecular Biology. Recurrent topics in Simrat Randhawa's work include Systemic Lupus Erythematosus Research (10 papers), Hepatitis C virus research (7 papers) and Liver Diseases and Immunity (4 papers). Simrat Randhawa is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Hepatitis C virus research (7 papers) and Liver Diseases and Immunity (4 papers). Simrat Randhawa collaborates with scholars based in United States, Netherlands and Philippines. Simrat Randhawa's co-authors include Cristina Arriens, Samir V. Parikh, Robert B. Huizinga, Y K Onno Teng, Dawn J. Caster, Laura Lisk, Ellen M. Ginzler, Keisha L. Gibson, Neil Solomons and Brad H. Rovin and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Simrat Randhawa

12 papers receiving 409 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

2021 299 citations Brad H. Rovin, Y K Onno Teng et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simrat Randhawa United States	6	362	168	160	103	95	13	424
Francesca Raffiotta Italy	10	351 1.0×	236 1.4×	187 1.2×	73 0.7×	66 0.7×	15	444
Isabelle Ravelingien Belgium	4	492 1.4×	298 1.8×	156 1.0×	157 1.5×	114 1.2×	6	527
Carmen Ho China	8	223 0.6×	69 0.4×	101 0.6×	43 0.4×	43 0.5×	14	286
Desmond YH Yap Hong Kong	8	181 0.5×	108 0.6×	79 0.5×	49 0.5×	39 0.4×	13	262
DD Gladman Canada	12	290 0.8×	22 0.1×	192 1.2×	20 0.2×	57 0.6×	19	341
Rocío V. Gamboa‐Cárdenas Peru	12	271 0.7×	33 0.2×	131 0.8×	14 0.1×	28 0.3×	44	351
Ka Lung Yu China	7	319 0.9×	20 0.1×	200 1.3×	32 0.3×	36 0.4×	9	351
Risto Perich-Campos Peru	10	248 0.7×	28 0.2×	139 0.9×	11 0.1×	41 0.4×	34	305
S Toloza United States	7	395 1.1×	15 0.1×	292 1.8×	33 0.3×	55 0.6×	8	456
Myron Chu United States	9	330 0.9×	23 0.1×	252 1.6×	16 0.2×	191 2.0×	14	395

Countries citing papers authored by Simrat Randhawa

Since Specialization

Citations

This map shows the geographic impact of Simrat Randhawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simrat Randhawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simrat Randhawa more than expected).

Fields of papers citing papers by Simrat Randhawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simrat Randhawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simrat Randhawa. The network helps show where Simrat Randhawa may publish in the future.

Co-authorship network of co-authors of Simrat Randhawa

This figure shows the co-authorship network connecting the top 25 collaborators of Simrat Randhawa. A scholar is included among the top collaborators of Simrat Randhawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simrat Randhawa. Simrat Randhawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Saxena, Amit, Ellen M. Ginzler, Keisha L. Gibson, et al.. (2023). Safety and Efficacy of Long‐Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial. Arthritis & Rheumatology. 76(1). 59–67. 49 indexed citations

Anders, Hans‐Joachim, et al.. (2022). 1110 Voclosporin is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations. SHILAP Revista de lepidopterología. A75.2–A76. 1 indexed citations

Dall’Era, Maria, Kenneth Kalunian, Michael Eaddy, et al.. (2022). Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United States. Journal of Managed Care & Specialty Pharmacy. 29(1). 36–45. 5 indexed citations

Arriens, Cristina, Y K Onno Teng, Ellen M. Ginzler, et al.. (2022). Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis. Arthritis Care & Research. 75(7). 1399–1408. 24 indexed citations

Rovin, Brad H., Y K Onno Teng, Ellen M. Ginzler, et al.. (2021). Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet. 397(10289). 2070–2080. 299 indexed citations breakdown →

Saxena, Amit, et al.. (2021). 514 Voclosporin for lupus nephritis: interim analysis of the AURORA 2 extension study. Abstracts. A20–A21. 1 indexed citations

Dall’Era, Maria, et al.. (2021). FC 035VOCLOSPORIN INCREASES RENAL RESPONSE AT COMMONLY USED UPCR THRESHOLDS IN PATIENTS WITH LUPUS NEPHRITIS. Nephrology Dialysis Transplantation. 36(Supplement_1).

Rovin, Brad H., Samir V. Parikh, Robert B. Huizinga, Neil Solomons, & Simrat Randhawa. (2020). Management of Lupus Nephritis (LN) with Voclosporin: An Update from a Pooled Analysis of 534 Patients. Journal of the American Society of Nephrology. 31(10S). 594–594. 4 indexed citations

Caster, Dawn J., Neil Solomons, Simrat Randhawa, & Robert B. Huizinga. (2020). MO019AURORA PHASE 3 TRIAL DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN). Nephrology Dialysis Transplantation. 35(Supplement_3). 2 indexed citations

10.

Arriens, Cristina, et al.. (2020). OP0277 AURORA PHASE 3 STUDY DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN). Annals of the Rheumatic Diseases. 79. 172–173. 29 indexed citations

11.

Meng, Xiangfei, et al.. (2015). Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly receiving selective serotonin-reuptake inhibitors. Multiple Sclerosis and Related Disorders. 4(3). 273–280. 8 indexed citations

12.

Bermel, Robert, et al.. (2014). Fingolimod First-Dose Effects In Patients With Relapsing-Remitting Multiple Sclerosis Concomitantly Treated With Serotonin-Specific Reuptake Inhibitors (P7.233). Neurology. 82(10_supplement). 1 indexed citations

13.

Singer, B., Mark Gudesblatt, Neetu Agashivala, et al.. (2014). Patient-Reported Outcomes After Therapy Switch to Fingolimod: Post-hoc Subgroup Analysis of the EPOC Study (P3.183). Neurology. 82(10_supplement). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact